Novo Nordisk Drops Lawsuit, Hims Enters Weight Loss Market
Irvine News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Novo Nordisk drops patent lawsuit against Hims, allowing direct sale of Wegovy and Ozempic. Hims shares surge 40% on settlement, entering weight loss market legally. Novo Nordisk may refile suit if issues arise, as FDA ends shortage status for compounded GLP-one drugs.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/285699a2b052a069